Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 25 July 1980:
Vol. 209. no. 4455, pp. 503 - 505
DOI: 10.1126/science.6771871
Prev | Table of Contents | Next

Articles

Science, Vol 209, Issue 4455, 503-505
Copyright © 1980 by American Association for the Advancement of Science

articles

Limitations of metabolic activation systems used with in vitro tests for carcinogens

CA Bigger, JE Tomaszewski, A Dipple, and RS Lake

Important differences between the metabolic activation of 7,12-dimethylbenz[a]anthracene in intact cellular systems and in liver homogenates suggest that the use of homogenates in conjunction with short-term assays for carcinogens could yield misleading results.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Both ({+/-})syn- and ({+/-})anti-7,12-Dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides Initiate Tumors in Mouse Skin That Possess -CAA- to -CTA- Mutations at Codon 61 of c-H-ras.
M.-s. Tang, S. V. Vulimiri, A. Viaje, J. X. Chen, D. S. Bilolikar, R. J. Morris, R. G. Harvey, T. J. Slaga, and J. DiGiovanni (2000)
Cancer Res. 60, 5688-5695
   Abstract »    Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)